<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="Tab1">
 <label>Table 1</label>
 <caption>
  <p>Characteristics of immunosenescence: decline in immune functions; and immune consequences of SARS-CoV-2 infection in older people</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th/>
    <th>
     <bold>Immune characteristics</bold>
    </th>
    <th>
     <bold>Mechanisms</bold>
    </th>
    <th>
     <bold>Consequences</bold>
    </th>
    <th>
     <bold>References</bold>
    </th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td>
     <italic>Immunosenescence</italic>
    </td>
    <td>SASP phenotype</td>
    <td>Inflammaging due to cells with SASP</td>
    <td>Chronic inflammatory state (IL-6)</td>
    <td>Coppe J-P et al., 2010</td>
   </tr>
   <tr>
    <td/>
    <td>Chronic stimulation</td>
    <td>Chronic infection such as Cytomegalovirus â†’ cells exhaustion and oligoclonal memory cell expansion; Accumulation of CMV-specific memory CD8+ T cells</td>
    <td>Memory inflation; T cells exhaustion</td>
    <td>Klenerman P et al., 2016</td>
   </tr>
   <tr>
    <td/>
    <td>Reduction of B and T cells production</td>
    <td>Stem cell aging with reduced capacity to produce lymphocytes, reduction in the number of B cell and T cell progenitors in bone marrow and thymus</td>
    <td>Vulnerability to infections and cancer; Impaired response to vaccination</td>
    <td>Goronzy JJ et al., 2019</td>
   </tr>
   <tr>
    <td/>
    <td>Reduction of mature lymptocytes functions</td>
    <td>Alteration of the composition and quality of the mature lymphocyte pool. Increased number of memory T cells</td>
    <td/>
    <td/>
   </tr>
   <tr>
    <td/>
    <td>Impaired B cells function</td>
    <td>B cell number reduced in peripheral blood. Decreased numbers of IgM+ memory and switched memory B cells</td>
    <td/>
    <td>Frasca D et al., 2009</td>
   </tr>
   <tr>
    <td/>
    <td>Compromise communication between innate and adaptive immunity</td>
    <td>Activated naive CD4 T cells have reduced responses to type I IFN</td>
    <td>Lack in the regulation of T cell differentiation and survival. Vulnerability to infections</td>
    <td>Shaw AC et al., 2010</td>
   </tr>
   <tr>
    <td/>
    <td>Low type I and III IFN response</td>
    <td>Reduced number of plasmacytoid dendritic cells IFN producers; inadequate CD4T cells response to type I IFN stimulation, that impairs IL-2 production and cell survival</td>
    <td/>
    <td>Agrawal A et al., 2013 Li et al., 2015</td>
   </tr>
   <tr>
    <td>
     <italic>SARS-CoV-2</italic>
    </td>
    <td>Low type I and III IFN response</td>
    <td>The host response to SARS-CoV-2 fails to launch robust type I and Type III IFN responses. No recruitment of effector cells</td>
    <td>Uncontrolled infection by the immune system and clinical severity</td>
    <td>Blanco-Melo D et al., 2020</td>
   </tr>
   <tr>
    <td/>
    <td>Lymphopenia</td>
    <td>SARS-CoV-2 could infect T cells. Apoptosis of lymphocytes induces lymphocytopenia like in MERS-CoV infection?</td>
    <td/>
    <td>Yang X et al., 2020 Wang X et al., 2020</td>
   </tr>
  </tbody>
 </table>
</table-wrap>
